Business leaders in the life sciences industry deal every day with one of the most complex supply chains imaginable. Theirs is a world of high-tech production processes, scattered over a hybrid, strongly intertwined network of internal and external production, and packaging and distribution nodes.
Commitment to patients is the prime concern, of course, while compliance with health regulations brings additional challenges. So how do you gain end-to-end visibility over your entire supply chain ecosystem? And how can you retain high product availability while keeping inventory and capacity buffers low? Here’s how OMP for Life Sciences helps companies navigate and overcome these challenges.
Global life sciences supply chains are very complex. Business leaders need to align interconnected production sites worldwide, and balance in-house production and contract manufacturing, while dealing with dual sourcing strategies from production to distribution.
OMP for Life Sciences builds a digital twin of your entire extended supply chain ecosystem. Its ‘one model, one plan’ logic provides an integrated platform for all stakeholders, offering full end-to-end visibility over the entire supply chain, including suppliers, CMOs, third-party logistics, and other partners, while seamlessly integrating all planning horizons, functions, and roles.
With its integrated logic, OMP for Life Sciences eliminates disconnects between planning horizons, allowing optimization at global level, and avoiding the risks inherent in making decisions with only partial supply chain visibility.
OMP for Life Sciences reconciles top service levels with profit optimization. It smartly adjusts production, packaging and distribution lines, capacities and networks, while optimizing inventory levels of intermediate and finished products, and synchronizing manufacturing equipment and packaging lines.
Capacity constraint solvers, self-learning data, data management, and integration features, all combine for a perfect sync between plan and reality. Attribute-based planning and pegging functionality allow you to plan for specific batch characteristics and shelf-life requirements, instead of planning on materials alone, letting you peg any demand and supply element according to rules integrated within the model, including regulatory constraints, quantity tolerance, and shelf-life.
OMP for Life Sciences allows all the departments involved in clinical and commercial production, regulatory approvals, and quality control to work together in unison. By handling regulatory issues as an additional planning constraint, the planning solution considers which in-house or CMO facilities are authorized to produce a particular drug substance or product for specific customer segments and regions, and in what specified time frame.
Throughput times for quality controls can be added to the planning, allowing priority-based batch planning to meet critical deadlines or serve key customers. You can, for example, more easily anticipate patent approval, plan your commercial production and distribution networks in advance, and orchestrate both clinical and commercial capacity planning — even with shared equipment, product lines, or reactors.
How can Unison Planning™ create additional value for every stakeholder? Here’s how one world leader in pharmaceuticals is making full use of OMP’s signature solution to deliver exactly that, as part of a major transformative business journey.Read case study
We know exactly how a fragmented and unpredictable demand puts pressure on production and distribution processes. Meet our experts.
Avanos Medical, Inc., a leading medical devices company, started using Unison PlanningTM with SAP S/4HANA. Using OMP for Life Sciences, Avanos has improved its planning maturity and E2E supply chain visibility successfully.Read the news
I have strong opinions about a debate that will probably never be settled (and it’s not about whether Ross and Rachel were on a break). It’s about whether companies should get their advanced supply chain planning solution customized to meet their specialized needs or instead adopt a standard template.Read the blog
Roche, a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives and the world’s largest biotech company, has begun implementing OMP as its supply chain planning system of record (SOR) in the pharmaceutical division.Read the news
To stay ahead of the curve, we participate in important supply chain events worldwide like LogiPharma, the world’s leading pharma supply chain event. It’s a great place to network, share expertise and gather new knowledge.
UCB has rolled out a full-scope OMP planning solution to ensure end-to-end visibility of their global supply chain. This integrated solution covers all supply chain planning functions: demand planning, executive S&OP, S&OP, inventory optimization, MPS, DRP, deployment, detailed scheduling and transport planning.Read the news
Syncing up the supply chain with the overall business strategy and targets is the foundation of success. OMP’s Philip Vervloesem makes the point.
More and more companies are investing in sustainability, and there’s a good reason for that: climate change is one of the biggest issues facing humanity and we’re already seeing the consequences, with increasingly severe floods, forest fires, shrinking ice caps, record temperatures and deadly droughts.Read the blog
Stef Vermeiren, Vice President Global Planning – Janssen Pharmaceutica at Johnson & Johnson
Dean Bergman, IT Director at Avanos Medical
Nathalie Loicq, Vice President Global Supply Chain at UCB
David Aherne, Senior Director Global Supply Chain at Alexion Pharmaceuticals
Steffen Heinecke, Project Lead for Global Supply Chain at Roche